Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone

Leukemia and Lymphoma

Volumn 48, Issue 8, 2007, Pages 1610-1617

  Srivastava, Maya D ^a,b   Thomas, Anil ^b   Srivastava, B I S ^c   Check, Jerome H ^d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Innate immune factors; Leukemia cells; Progesterone induced blocking factor

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CELL PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE; POLYPEPTIDE ANTIBIOTIC AGENT; PROGESTERONE; TOLL LIKE RECEPTOR 4;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BONE MARROW CULTURE; CD34 SELECTION; CELL LINEAGE; CELL STRAIN HL 60; CELL STRAIN U937; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EPITHELIUM CELL; FIBROBLAST CULTURE; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LEUKEMIA CELL LINE; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; MONOCYTE; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; T LYMPHOCYTE;

ALPHA-DEFENSINS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE ANTAGONISTS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; KILLER CELLS, NATURAL; LEUKEMIA; MIFEPRISTONE; PREGNANCY PROTEINS; PROGESTERONE; PROGESTINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPRESSOR FACTORS, IMMUNOLOGIC; TOLL-LIKE RECEPTOR 4; TUMOR CELLS, CULTURED;

EID: 34547997365     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701471999     Document Type: Article

References (38)

1. Check, J. H., Chase, J. S., Nowroozi, K., Wu, C. H. and Adelson, H. G. (1987) Progesterone therapy to decrease first trimester spontaneous abortions in previous aborters. Int J Fertil, 32, pp. 192-193.
2. Check, J. H. and Adelson, H. G. (1987) The efficacy of progesterone in achieving successful pregnancy. II. In women with pure luteal phase defects. Int J Fertil, 32, pp. 139-141.
3. Check, J. H., Nowroozi, K., Wu, C. H., Adelson, H. G. and Lauer, C. (1988) Ovulation-inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects. Int J Fertil, 33, pp. 252-256.
4. Formigli, L., Roccio, C., Belotti, G., Stangalini, A., Coglitore, M. T. and Formigli, G. (1989) Oocyte donation by gamete intrafallopian transfer to amenorrheic and cycling patients given replacement steroids. Hum Reprod, 4, pp. 772-776.
5. Dubois, C., Ulmann, A. and Baulieu, E. E. (1988) Contragestion with late luteal administration of RU486 (mifepristone). Fertil Steril, 50, pp. 593-596.
6. Lahteenmaki, P., Rapeli, T., Kaariainen, M., Alfthan, H. and Ylikorkala, O. (1988) Late postcoital treatment against pregnancy with antiprogesterone RU486. Fertil Steril, 50, pp. 36-38.
7. Bygdeman, M. and Swahn, M. L. (1985) Progesterone receptor blockage: effect on uterine contractility and early pregnancy. Contraception, 32, pp. 45-51.
8. Bouman, A., Heineman, M. J. and Faas, M. M. (2005) Sex hormones and the immune response in humans. Hum Reprod Update, 11, pp. 411-423.
9. Srivastava, M. and Anderson, D JA (2007) Progesterone receptor expression by human leukocyte cell lines: Molecular mechanisms of cytokine suppression. Clin Exp Obst Gyn, 34, pp. 14-24.
10. Szekeres-Bartho, J., Kilar, F., Falkay, G., Csernus, V., Torok, A. and Pacsa, A. S. (1985) The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity I. Progesterone treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol, 9, pp. 15-18.
11. Szekeres-Bartho, J., Autran, B., Debre, P., Andreu, G., Denver, L. and Chaouat, G. (1989) Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol, 122, pp. 281-294.
12. Szekeres-Bartho, J., Faust, Zs and Varga, P. (1995) Progesterone-induced blocking factor (PIBF) in normal and pathological pregnancy. Am J Reprod Immunol, 34, pp. 342-348.
13. Faust, Z., Laskarin, G., Rukavina, D. and Szekeres-Bartho, J. (1999) Progesterone induced blocking factor inhibits degranulation of NK cells. Am J Reprod Immunol, 42, pp. 71-75.
14. Szekeres-Bartho, J., Reznikoff-Etievant, M. F., Varga, P., Varga, Z. and Chaouat, G. (1989) Lymphocyte progesterone receptors in human pregnancy. J Reprod Immunol, 16, pp. 239-247.
15. Szekeres-Bartho, J., Szekeres, Gy, Debre, P., Autran, B. and Chaouat, G. (1990) Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol, 125, pp. 273-283.
16. Chiu, L., Nishimure, M., Ishii, Y., Nieda, M., Maeshima, M. and Takedani, Y. (1996) Enhancement of the expression of progesterone receptor on progesterone-treated lymphocytes after immunotherapy in unexplained spontaneous abortion. Am J Reprod Immunol, 35, pp. 552-557.
17. Polgar, B., Barakonyi, A., Xynos, I. and Szekeres-Bartho, J. (1999) The role of γ/σ T cell receptor positive cells in pregnancy. Am J Reprod Immunol, 41, pp. 239-244.
18. Szekeres-Bartho, J., Faust, Z., Varga, P., Szerday, L. and Kelemen, K. (1996) The immunological pregnancy protective effects of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol, 35, pp. 348-351.
19. Szekeres-Bartho, J., Par, G., Dombay, G., Smart, C. Y. and Volgyi, Z. (1997) The anti-abortive effect of PIBF in mice is manifested by modulating NK activity. Cell Immunol, 177, pp. 194-199.
20. Makhseed, M., Raghupathy, R., Azizieh, F., Omu, A., Al-Shamali, E. and Ashkanani, L. (2001) Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod, 16, pp. 2219-2226.
21. Makhseed, M., Raghupathy, R., El-Shazly, S., Azizieh, F., Al-Harmi, J. A. and Al-Azemi, M. M. (2003) Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol, 49, pp. 308-318.
22. Szekeres-Bartho, J., Faust, Zs and Varga, P. (1995) The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol, 34, pp. 342-348.
23. Szekeres-Bartho, J., Weill, B. J., Mike, G., Houssin, D. and Chaouat, G. (1989) Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol Lett, 22, pp. 259-261.
24. Check, J. H., Arwitz, M., Gross, J., Peymer, M. and Szekeres-Bartho, J. (1997) Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF). J Reprod Immunol, 37, pp. 17-20.
25. Lachmann, M., Gelbmann, D., Kalman, E., Polgar, B., Buschle, M. and von Gabain, A. (2004) PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with centrosome. Int J Cancer, 112, pp. 51-60.
26. Szekeres-Bartho, J., Autran, B., Debre, P., Andreu, G., Denver, L. and Chaouat, G. (1989) Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell immunol, 122, pp. 281-294.
27. Srivastava, M. D. and Srivastava, B. I. (2005) Expressionof mRNA and proteins for toll-like receptors, associated molecules, defensins, and LL-37 by SRIK-NKL, A CD8 + NK/T cell line. Leuk Res, 29, pp. 813-820.
28. Kanai, Y., Ushingima, S., Dondo, Y., Nakanishi, Y. and Hirshashi, S. (2001) DNA methyltransferase expression and DNA methylation of stomach cancers. Int J Cancer, 91, pp. 205-212.
29. Stroinigg, N. and Srivastava, M. D. (2005) Modulation of toll like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defeusm 2. Allergy Asthma Proc, 26, pp. 299-309.
30. Polgar, P., Kispal, G., Lachmann, M., Paar, C., Nagy, E. and Csere, P. (2003) Molecular cloning and immunological characterization of a novel cDNA coding for PIBF. J Immunol, 171, pp. 5956-5963.
31. Check, J. H., Ostrzenski, A. and Klimek, R. (1997) Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. Am J Reprod Immunol, 37, pp. 330-334.
32. Check, J. H., Nazari, P., Goldberg, J., Yuan, W. and Angotti, D. (2001) A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. Med Hypoth, 57, pp. 337-343.
33. Kozma, N., Halasz, M., Polgar, B., Poehlmann, T. G., Markert, U. R. and Palkovics, T. (2006) Progesterone-induced blocking factor activates STAT 6 via binding to a novel IL-4 receptor. J Immunol, 176, pp. 819-826.
34. Lee, G. W., Boomer, J. S., Gilman-Sachs, A., Chedid, A., Gudelj, L. and Rukavina, D. (2001) Regeneration and tolerance factor of the human placenta induces IL-10 production. Eur J Immunol, 31, pp. 687-691.
35. Aslakson, C. J., Lee, G., Boomer, J. S., Gilman-Sachs, A., Kucuk, O. and Beaman, K. D. (1999) Expression of regeneration and tolerance factor on B cell chronic lymphocytic leukemias: A possible mechanism for escaping immune surveillance. Am J Hematol, 61, pp. 46-52.
36. Naganuma, H., Kono, K., Mori, Y., Takayoshi, S., Stern, P. L. and Tasaka, K. (2002) Oncofetal antigen 5T4 expression as a prognostic factor in patients with gastric cancer. Anticancer Res, 22, pp. 1033-1038.
37. Kopreski, M. S., Benko, F. A. and Gocke, C. D. (2001) Circulating RNA as a tumor marker: Detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci, 945, pp. 172-178.
38. Kloosterboer, H. J., Deckers, G. H. and Schoonen, W GEJ (1994) Pharmacology of two new very selective antiprogestagins: Org 31710 and Org 31806. Progesterone Antagonists in Reproductive Medicine and Oncology, pp. 47-52. Oxford University Press, Oxford